Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

65 results
  1. ... but they typically do not show signs and symptoms of the condition. Other Names for This Condition Acid maltase deficiency Acid maltase deficiency disease Alpha-1,4-glucosidase ...
  2. ... hypertrophic cardiomyopathy. The diagnosis is based on complete deficiency of activity of the ... Following Initial Diagnosis To establish the extent of disease and needs ...
  3. ... s disease, β-mannosidosis, mucolipidosis III or IV, glycogen storage disease type II ... HSCT compared with symptom management or disease natural history. All five patients ...
  4. ... maltase</synonym><synonym >Lysosomal glycogen storage disease without acid maltase deficiency</synonym><synonym >X-linked pseudoglycogenosis II</synonym><synonym > ...
  5. ... name><other_name >Lysosomal glycogen storage disease without acid maltase deficiency</other_name><other_name >X-linked pseudoglycogenosis II</ ...
  6. ... Acid lipase deficiency, see Lysosomal acid lipase deficiency Acid maltase deficiency, see Pompe disease Acid maltase deficiency disease, see Pompe disease ACLS, see Acrocallosal syndrome ...
  7. ... for the treatment of Type 1 Gaucher disease. Glycogen Storage Disease type II (Pompe Disease) Eight studies of alglucosidase alfa as treatment for glycogen storage disease type II (Pompe disease) are summarized in Table 10 . 72 – ...
  8. ... normal acid maltase Lysosomal glycogen storage disease without acid maltase deficiency X-linked pseudoglycogenosis II X-linked vacuolar cardiomyopathy ...
  9. ... see Danon disease Lysosomal glycogen storage disease without acid maltase deficiency, see Danon disease Lysosomal protective protein deficiency, see ...
  10. ... et al. Progress in enzyme replacement therapy in glycogen storage disease type II. Therapeutic Advances in Neurological Disorders. 2009; 2 (3): ... therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study. J Inherit ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · next · last